GTCR Announces Agreement To Acquire Sterigenics International, Inc.

CHICAGO, IL – February 23, 2011 – GTCR, a leading private equity firm, today announced it has signed a definitive agreement with Silverfleet Capital and PPM America Capital Partners to acquire Sterigenics International, Inc. (“Sterigenics”), the leading global provider of contract sterilization and ionization services for medical devices, food products, and advanced applications. The transaction […]


GTCR Closes $3.25 Billion Buyout Fund

Leading Private Equity Firm Exceeds Target in Just Seven Months CHICAGO, IL – February 22, 2011 – GTCR, one of the nation’s leading private equity firms today announced the final closing of its tenth buyout fund, with more than $3.25 billion of equity capital commitments. The fund, which had a target of $3 billion, was […]


GTCR Announces Agreement to Sell Fairmount Cheese Holdings

Chicago, IL, February 17, 2011 – GTCR, a leading private equity firm, today announced its portfolio company, Fairmount Cheese Holdings Inc. (“Fairmount”), parent company of DCI Cheese Company Inc. (“DCI”), has signed a definitive agreement to be purchased by Saputo Inc. (“Saputo”).  Fairmount is one of the largest national suppliers of specialty cheese, dips and […]


GTCR Announces Partnership with Joseph Ripp to Form Cannondale Holdings

Chicago, IL, February 10, 2010 – GTCR, a leading private equity firm, today announced it has entered into a partnership with Joseph Ripp to form Cannondale Holdings. The new company, headquartered in Wilton, Connecticut, will focus on acquiring data-enabled information and marketing services firms that deliver timely and actionable data to clients to improve decision […]


Actient Pharmaceuticals LLC Announces Acquisition of Timm Medical Technologies, Inc.

Lake Forest, IL, January 24, 2011 – Actient Pharmaceuticals LLC (“Actient”), a specialty pharmaceutical company, announced today that it has acquired Timm Medical Technologies, Inc. (“Timm Medical”). Timm Medical is a recognized leader in products and services for the diagnosis and treatment of urological disorders, primarily in the area of erectile dysfunction. The acquisition of […]


GTCR Announces Partnership with David Minella to Form Aligned Asset Managers

CHICAGO, January 11, 2011 – GTCR, a leading private equity firm, today announced it has entered into a partnership with David Minella to form Aligned Asset Managers, LLC (“AAM”).  AAM, headquartered in Stamford, Connecticut, will focus on building a leading multi-strategy asset management platform through substantial equity investments in firms across alternative and traditional asset […]


GTCR Announces Portfolio Company Six3 Systems’ Acquisition of Novii Design, LLC

Chicago, IL, September 29, 2010 – GTCR announced today that portfolio company Six3 Systems, Inc. (“Six3 Systems”), a leading provider of highly strategic and differentiated solutions and services to the U.S. national security and defense intelligence communities, has acquired Novii Design, LLC (“Novii”). Novii is a leading prime provider of large scale data fusion systems, […]


GTCR Announces Agreement to Sell National Processing Company

CHICAGO, IL – September 14, 2010 – GTCR, a leading private equity firm, today announced its portfolio company, National Processing Company (NPC), has signed a definitive purchase agreement with Fifth Third Processing Solutions, LLC. NPC is one of the largest U.S. merchant acquirers providing integrated electronic payment solutions and services targeted exclusively toward the small […]


GTCR Announces Partnership with Dale Wolf to Form Jessamine Healthcare

CHICAGO, August 3, 2010 – GTCR, one of the nation’s leading private equity firms, today announced it has entered into a partnership with Dale Wolf to form Jessamine Healthcare, Inc. The new company, headquartered in Rockville, Maryland, will focus on acquiring companies in the healthcare payor and outsourced payor services industries. Mr. Wolf, who will […]


GTCR Portfolio Company, Actient Pharmaceuticals, Closes Transaction to License and Acquire Specialty Products from UCB, Inc.

Acquisition Bolsters Partnership with Industry Leader Ed Fiorentino CHICAGO, IL – July 29, 2010 – GTCR, one of the country’s leading private equity firms, announced today that Actient Pharmaceuticals, LLC has successfully completed a transaction to license and acquire six pharmaceutical products from UCB, Inc., a subsidiary of UCB SA, an international biopharmaceutical company based […]



Page 5 of 9« First...34567...Last »